期刊文献+

Increased stromal-cell-derived factor 1 enhances the homing of bone marrow derived mesenchymal stem cells in dilated cardiomyopathy in rats 被引量:5

Increased stromal-cell-derived factor 1 enhances the homing of bone marrow derived mesenchymal stem cells in dilated cardiomyopathy in rats
原文传递
导出
摘要 Background Stem cell transplantation has been shown to have beneficial effects on dilated cardiomyopathy. However, mechanism for stem cell homing to cardiac tissue in dilated cardiomyopathy has not yet been elucidated. Methods Mesenchymal stem cells were obtained from rat bone marrow, expanded in vitro, and labeled with 99mmc. Cardiomyopathy model was induced by doxorubicin in rats. 9ernTC labeled cells were infused into the left ventricles in cardiomyopathy and control rats. Sixteen hours after injection, animals were sacrificed and different tissues were harvested to measure specific radioactivity. By use of real-time polymerase chain reaction and immunohistochemistry, mRNA and protein expressions for stromal-cell-derived factor 1 in cardiac tissue were measured. Results Labeling efficiency of mesenchymal stem cells was (70.0±11.2)%. Sixteen hours after mesenchymal stem cell transplantation, the heart-to-muscle radioactivity ratio was increased significantly in cardiomyopathy hearts as compared to control hearts. Both mRNA and protein expressions of cardiomyopathy hearts as compared with control hearts. Conclusion In dilated cardiomyopathy induced by doxorubicin in heart may induce mesenchymal stem cells home to the heart. stromal-cell-derived factor 1 were up-regulated in up-regulated expression of stromal-cell-derived factor I Background Stem cell transplantation has been shown to have beneficial effects on dilated cardiomyopathy. However, mechanism for stem cell homing to cardiac tissue in dilated cardiomyopathy has not yet been elucidated. Methods Mesenchymal stem cells were obtained from rat bone marrow, expanded in vitro, and labeled with 99mmc. Cardiomyopathy model was induced by doxorubicin in rats. 9ernTC labeled cells were infused into the left ventricles in cardiomyopathy and control rats. Sixteen hours after injection, animals were sacrificed and different tissues were harvested to measure specific radioactivity. By use of real-time polymerase chain reaction and immunohistochemistry, mRNA and protein expressions for stromal-cell-derived factor 1 in cardiac tissue were measured. Results Labeling efficiency of mesenchymal stem cells was (70.0±11.2)%. Sixteen hours after mesenchymal stem cell transplantation, the heart-to-muscle radioactivity ratio was increased significantly in cardiomyopathy hearts as compared to control hearts. Both mRNA and protein expressions of cardiomyopathy hearts as compared with control hearts. Conclusion In dilated cardiomyopathy induced by doxorubicin in heart may induce mesenchymal stem cells home to the heart. stromal-cell-derived factor 1 were up-regulated in up-regulated expression of stromal-cell-derived factor I
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第22期3282-3287,共6页 中华医学杂志(英文版)
基金 This study was supported by the National Natural Science Foundation of China (No. 30900603), Specialized Research Fund for the Doctoral Program of Higher Education (No. 20093234110008 and No. 20093234120008), and Project Supported by Department of Health of Jiangsu Province (No. ZX07 200902)
关键词 mesenchymal stem cells stromal-cell-derived factor 1 CARDIOMYOPATHY mesenchymal stem cells stromal-cell-derived factor 1 cardiomyopathy
  • 相关文献

参考文献37

  • 1Schoenhard JA,Hatzopoulos AK.Stem cell therapy:pieces of the puzzle.J Cardiovasc Transl Res 2010; 3:49-60.
  • 2Seth S,Narang R,Bhargava B,Ray R,Mohanty S,Gulati G,et al.AIIMS Cardiovascular Stem Cell Study Group.Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy:clinical and histopathological results:the first-in-man ABCD (autologous bone marrow cells in dilated cardiomyopathy) trial.J Am Coll Cardiol 2006; 48:2350-2351.
  • 3Orlic D,Hill JM,Arai AE.Stem cells for myocardial regeneration.Circ Res 2002; 91:1092-1102.
  • 4Arguero R,Careaga-Reyna G,Castano-Guerra R,Garrido-Garduno MH,Magana-Serrano JA,de Jesus Nambo-Lucio M.Cellular autotransplantation for ischemic and idiopathic dilated cardiomyopathy.Preliminary report.Arch Med Res 2006; 37:1010-1014.
  • 5Nagaya N,Kangawa K,Itoh T,Iwase T,Murakami S,Miyahara Y,et al.Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy.Circulation 2005; 112:1128-1135.
  • 6Benetti F,Pe(n)herrera E,Maldonado T,Vera YD,Subramanian V,Geffner L.Direct myocardial implantation of human fetal stem cells in heart failure patients:long-term results.Heart Surg Forum 2010; 13:E31-E35.
  • 7Ohnishi S,Yanagawa B,Tanaka K,Miyahara Y,Obata H,Kataoka M,et al.Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis.J Mol Cell Cardiol 2007; 42:88-97.
  • 8Peled A,Petit I,Kollet O,Magid M,Ponomaryov T,Byk T,et al.Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4.Science 1999;283:845-848.
  • 9Zaruba MM,Franz WM.Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy.Expert Opin Biol Ther 2010; 10:321-335.
  • 10Kollet O,Shivtiel S,Chen YQ,Suriawinata J,Thung SN,Dabeva MD,et al.HGE SDF-1,and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver.J Clin Invest 2003; 112:160-169.

同被引文献18

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部